You are here: Industry Insights > hydroxychloroquine

News List

India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19 expresspharma
April 16, 2020
India has agreed to sell hydroxychloroquine (HCQ) tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters recently, with New Delhi partially lifting its bar on exports of the anti-malarial drug.
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries worldpharmanews
April 15, 2020
Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world, and has begun to progressively deliver the medicine to authorities that have requested it.
Fast tracks testing of COVID-19 therapies worldpharmanews
April 14, 2020
A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched at UPMC to address one of the most important debates during the COVID-19 pandemic.
Mylan Updates COVID-19 Response americanpharmaceuticalreview
April 14, 2020
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
Indian pharma industry best placed to play key role in global supply of hydroxychloroquine amid COVID-19 pandemic: GlobalData expresspharma
April 14, 2020
Prashant Khadayate, Practice Head of Healthcare at GlobalData writes about out how India can supplement the acute need for hydroxychloroquine during the ongoing COVID-19 pandemic.
Affiliate of Lupus Research Alliance Developing Study Focused on Lupus Patients and COVID-19 americanpharmaceuticalreview
April 13, 2020
Lupus Therapeutics announced is embarking on a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus therapies in preventing or reducing the symptoms of COVID-19 in people with lupus.
NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19 drugs
April 10, 2020
A clinical trial to assess the antimalarial drug hydroxychloroquine as a treatment for adults with the novel coronavirus (COVID-19) is now underway.
Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19 worldpharmanews
April 09, 2020
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware ...
Limited supply of antimalarial drugs may prevent use against COVID-19, say doctors europeanpharmaceuticalreview
April 08, 2020
An open letter from doctors highlights that although chloroquine and hydroxychloroquine are strong candidates to fight COVID-19, there is a limited supply.
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine americanpharmaceuticalreview
April 06, 2020
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore being considered as possible treatment for COVID-19.

Previous page 1 2 3 4 5 6 Next page